Reshape Lifesciences Inc Stock Nasdaq
Equities
US7611231082
Advanced Medical Equipment & Technology
Sales 2024 * | 9.99M 13.7M | Sales 2025 * | 11.99M 16.44M | Capitalization | 3.92M 5.37M |
---|---|---|---|---|---|
Net income 2024 * | -6M -8.23M | Net income 2025 * | -5M -6.86M | EV / Sales 2024 * | 0.39 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.33 x |
P/E ratio 2024 * |
-0.37
x | P/E ratio 2025 * |
-0.46
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.83% |
Latest transcript on Reshape Lifesciences Inc
Managers | Title | Age | Since |
---|---|---|---|
Paul Hickey
CEO | Chief Executive Officer | 59 | 20-01-31 |
Director of Finance/CFO | 63 | 21-06-14 | |
Dov Gal
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Blackford
BRD | Director/Board Member | 66 | 15-12-31 |
Dan Gladney
CHM | Chairman | 70 | 15-10-31 |
Director/Board Member | 70 | 21-06-14 |
1st Jan change | Capi. | |
---|---|---|
+8.33% | 219B | |
+6.72% | 183B | |
+10.18% | 132B | |
+24.91% | 106B | |
-2.09% | 62.09B | |
+10.56% | 50.8B | |
+4.81% | 50.88B | |
-0.24% | 40.64B | |
+1.22% | 35.71B |